查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1499544

醫療保健契約製造市場：按製造類型、最終用戶分類 - 2024-2030 年全球預測

Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年醫療保健契約製造市場規模為1,860億美元，預計2024年將達2016.8億美元，2030年將達3,292.2億美元，複合年成長率為8.49%。

醫療保健契約製造市場由向其他醫療保健組織提供各種服務的公司組成，從藥物處方和市場開拓到製造醫療保健設備和組件。這個市場允許醫療保健公司外包部分業務，降低成本，提高靈活性，並利用先進的製造技術和專業知識。推動該市場成長的關鍵因素包括對學名藥的需求增加、慢性病的流行、對先進醫療設備的需求以及新治療方式的快速採用。然而，嚴格的監管合規性、各種國際標準以及在降低成本的同時保持高品質流程的壓力是阻礙市場成長的主要阻礙因素。醫療保健契約製造市場的機會是由技術進步驅動的，例如設備製造中的 3D 列印、個人化醫療保健以及日益重要的監管合規性。此外，持續投資研發創新生技藥品和醫療保健設備並適應不斷發展的數位醫療保健格局可能會進一步加劇市場競爭。

主要市場統計
基準年[2023] 1860億美元
預測年份 [2024] 2016.8億美元
預測年份 [2030] 3292.2億美元
複合年成長率（%） 8.49%

區域洞察

由於其高度發達的醫療基礎設施和嚴格的監管要求，美洲正在經歷顯著的市場成長。由於越來越注重降低醫療保健成本，北美地區對受託製造廠商(CMO) 的外包（尤其是藥品和醫療保健設備）正在迅速增加。由於政府的大力支持以及學術界和工業界的合作，歐洲國家處於醫療保健研究和開發的前沿。公共和私營部門在個人化醫療、基因組學、數位健康解決方案和先進療法等領域的投資不斷增加，進一步支持了歐洲、中東和非洲醫療保健契約製造的成長。由於國內需求成長、成本優勢和技術進步，中國、日本和印度的醫療保健契約製造正在顯著成長。亞太地區正在成為醫療保健設備和藥品的製造地，導致受託製造公司在亞太市場的策略擴張。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在醫療保健契約製造市場中的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對醫療保健契約製造市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該細分市場競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在醫療保健契約製造市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行概述

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥公司端到端外包趨勢增加
      • 契約製造製造商增加對先進製造技術的投資
      • 對一站式合約開發和製造組織的需求不斷增加
    • 抑制因素
      • 外包中的合規問題以及嚴格的法規和法律體制
    • 機會
      • 更加關注核子衛生保健和特種藥物
      • 生物治療的需求不斷增加
    • 任務
      • 影響醫療保健契約製造組織盈利的產能利用率問題
  • 市場區隔分析
    • 製造類型：製造流程的進步提供客製化解決方案，透過契約製造滿足不同的客戶需求。
    • 最終用戶：契約製造開始開發高度複雜的生物產品。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 醫療保健合約契約製造市場：依製造類型

  • 介紹
  • 配件製造
  • 組裝製造
  • 零件製造
  • 裝置製造
  • 藥品製造

第7章 醫療保健契約製造市場：依最終用戶分類

  • 介紹
  • 醫療保健設備公司
  • 製藥和生物製藥公司

第8章美洲醫療保健合約契約製造市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太醫療保健契約製造市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的醫療保健契約製造市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biomerics 宣布與 Precision Concepts Medical 合併
    • PCI Pharma 宣布投資 5,000 萬美元擴建伊利諾伊州注射廠計劃
    • Medisurge 與 Signal Medical 宣布策略夥伴關係
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-8C74ADFC054D

[190 Pages Report] The Healthcare Contract Manufacturing Market size was estimated at USD 186.00 billion in 2023 and expected to reach USD 201.68 billion in 2024, at a CAGR 8.49% to reach USD 329.22 billion by 2030.

The healthcare contract manufacturing market comprises firms that offer a range of services, from drug formulation and development to medical devices and components manufacturing for other healthcare organizations. This market enables healthcare companies to outsource certain aspects of their operations, which can lead to lowered costs, increased flexibility, and access to advanced manufacturing technologies and expertise. The major factors propelling the growth of the healthcare contract manufacturing market include the increasing demand for generic medicines, the rising prevalence of chronic diseases, the need for advanced medical devices, and the surge in the introduction of new therapeutic methodologies. However, stringent regulatory compliances, varying international standards, and the pressure of maintaining high-quality processes while reducing costs are the major restraining factors hindering market growth. The opportunities within the healthcare contract manufacturing market are driven by technological advancements such as 3D printing in device manufacturing, personalized medicine, and the growing importance of regulatory compliance. Additionally, sustained investments in R&D for developing innovative biologics and medical devices and adapting to the evolving digital healthcare landscape could further enhance market competitiveness.

KEY MARKET STATISTICS
Base Year [2023] USD 186.00 billion
Estimated Year [2024] USD 201.68 billion
Forecast Year [2030] USD 329.22 billion
CAGR (%) 8.49%

Regional Insights

The Americas has significant market growth due to highly developed healthcare infrastructure and stringent regulatory requirements in the region. The increased focus on bringing down healthcare costs has led to a surge in outsourcing to contract manufacturing organizations (CMOs), particularly for pharmaceuticals and medical devices in the North American region. European Countries are at the forefront of healthcare research and development, bolstered by strong government support and collaborations between academia and industry. The growing investments from the public and private sectors in areas such as personalized medicine, genomics, digital health solutions, and advanced therapies further drive the growth of healthcare contract manufacturing in the EMEA region. China, Japan, and India are witnessing significant growth in healthcare contract manufacturing due to rising domestic demand, cost advantages, and technological advances. The Asia Pacific (APAC) region has emerged as a medical device and pharmaceutical manufacturing hub, leading to strategic business expansions by contract manufacturing organizations in the APAC market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Healthcare Contract Manufacturing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • Rising investments in advanced manufacturing technologies by contract manufacturers
      • Increasing demand for one-stop-shop contract development & manufacturing organization
    • Market Restraints
      • Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
    • Market Opportunities
      • Growing focus on nuclear medicine and specialty drugs
      • Increasing need for biological therapies
    • Market Challenges
      • Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
  • Market Segmentation Analysis
    • Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
    • End-User: Contract manufacturers expanded penetration to develop highly complex biological products
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Healthcare Contract Manufacturing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Healthcare Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Biomerics Announces Merger with Precision Concepts Medical

Biomerics LLC, a major player in vertically integrated contract manufacturing in the interventional medical device sector, has announced its strategic merger with Precision Concepts Medical. This significant transaction encompasses the acquisition of Precision Concepts International's (PCI) medical business and Precision Concepts Group (PCG), headquartered in Winston-Salem, North Carolina. This merger between Biomerics LLC and Precision Concepts Medical strengthened their presence in the healthcare contract manufacturing landscape. [Published On: 2023-05-17]

PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site

PCI Pharma Services, a biopharmaceutical contract manufacturing organization, recently announced its plans for a significant USD 50 million expansion at its Rockford, Illinois-based sterile injectables facility. The project is expected to involve the construction of a state-of-the-art 200,000-square-foot site that aims to substantially enhance the plant's production capacity for injectable drug-device combination products. The ambitious expansion initiative underscores PCI Pharma Services' commitment to addressing the growing demand for high-quality sterile injectable solutions while maintaining its position as a trusted and reliable partner in the biopharmaceutical sector. [Published On: 2023-03-16]

Medisurge and Signal Medical Announce Strategic Partnership

Medisurge, a healthcare contract manufacturing player, has announced its exclusive partnership with Signal Medical Corporation. Signal Medical has built a solid reputation for manufacturing high-quality knee and hip implants and providing advanced instrument systems to orthopedic surgeons. This strategic partnership between Medisurge and Signal Medical facilitates growth expansion for both companies in the competitive orthopedic market. By combining their expertise and resources, the partnership aims to establish an even stronger presence and provide enhanced services to clients within the industry. [Published On: 2023-01-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Healthcare Contract Manufacturing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Manufacturing Type
    • Accessories Manufacturing
    • Assembly Manufacturing
    • Component Manufacturing
    • Device Manufacturing
    • Pharmaceutical Manufacturing
      • Advanced Drug Delivery Formulations
      • API/Bulk Drugs
      • Finished Dose Formulations
      • Packaging
  • End-Users
    • Medical Device Companies
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • 5.1.1.2. Rising investments in advanced manufacturing technologies by contract manufacturers
      • 5.1.1.3. Increasing demand for one-stop-shop contract development & manufacturing organization
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on nuclear medicine and specialty drugs
      • 5.1.3.2. Increasing need for biological therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
    • 5.2.2. End-User: Contract manufacturers expanded penetration to develop highly complex biological products
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Healthcare Contract Manufacturing Market, by Manufacturing Type

  • 6.1. Introduction
  • 6.2. Accessories Manufacturing
  • 6.3. Assembly Manufacturing
  • 6.4. Component Manufacturing
  • 6.5. Device Manufacturing
  • 6.6. Pharmaceutical Manufacturing

7. Healthcare Contract Manufacturing Market, by End-Users

  • 7.1. Introduction
  • 7.2. Medical Device Companies
  • 7.3. Pharmaceutical & Biopharmaceutical Companies

8. Americas Healthcare Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Biomerics Announces Merger with Precision Concepts Medical
    • 11.3.2. PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
    • 11.3.3. Medisurge and Signal Medical Announce Strategic Partnership
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HEALTHCARE CONTRACT MANUFACTURING MARKET DYNAMICS
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM HEALTHCARE CONTRACT MA